6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinolin-3-amine

ID: ALA5191872

Chembl Id: CHEMBL5191872

PubChem CID: 168289848

Max Phase: Preclinical

Molecular Formula: C17H23N3O2

Molecular Weight: 301.39

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2cc(N)cnc2cc1OCCCN1CCCC1

Standard InChI:  InChI=1S/C17H23N3O2/c1-21-16-10-13-9-14(18)12-19-15(13)11-17(16)22-8-4-7-20-5-2-3-6-20/h9-12H,2-8,18H2,1H3

Standard InChI Key:  IIBHWWPTPAITJL-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5191872

    ---

Associated Targets(Human)

EHMT2 Tchem Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 (93046 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SETDB1 Tbio Histone-lysine N-methyltransferase SETDB1 (88 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SUV39H1 Tchem Histone-lysine N-methyltransferase SUV39H1 (101 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 301.39Molecular Weight (Monoisotopic): 301.1790AlogP: 2.69#Rotatable Bonds: 6
Polar Surface Area: 60.61Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.20CX LogP: 1.47CX LogD: -0.33
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.83Np Likeness Score: -1.00

References

1. Randazzo P, Sinisi R, Gornati D, Bertuolo S, Bencheva L, De Matteo M, Nibbio M, Monteagudo E, Turcano L, Bianconi V, Peruzzi G, Summa V, Bresciani A, Mozzetta C, Di Fabio R..  (2022)  Identification and in vitro characterization of a new series of potent and highly selective G9a inhibitors as novel anti-fibroadipogenic agents.,  72  [PMID:35718104] [10.1016/j.bmcl.2022.128858]

Source